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An experimental procedure is described for the reproducible production of hybridoma cells using the elec- 
trofusion technique. High yields can be obtained when fusion is performed in isotonic inositol solutions 
containing Ca*+ and Mg*+ m a ratio of 1: 5 in the millimolar range. The hybridoma cells are transferred 
10 min after the field pulse application i to a balanced salt solution for 30 min at 37 “C. 
Hybridoma Electrofusion Fusion medium 
1. INTRODUCTION 
In the last few years it has been possible to 
demonstrate that a great diversity of plant and 
animal cells can be fused by means of electrical 
fields [l-8]. In the meantime, this technique, 
which was developed in our laboratory 19-121, has 
become established in many laboratories, and a 
number of reports on electrofusion have already 
been published [13-241. In the light of these 
reports, the viability of electrofused hybrids 
should be beyond any doubt. 
In many cases, the recently published methods 
are the same with respect o the application of one 
or more DC pulses of short duration, but differ in 
the various methods of inducing the membrane 
contact necessary for fusion. For example, in the 
magneto-electrofusion technique [25], membrane 
contact is achieved by the action of inhomogeneous 
magnetic fields on magnetically labelled cells. In 
some published studies fusion is induced by the ap- 
plication of electric field pulses to a monolayer of 
cells in which cell contact has been achieved by the 
cells growing together [ 18,191 or by means of a 
specific chemical reaction of pretreated cells [26]. 
The electrofusion of lymphocytes and myeloma 
cells for the production of hybridoma cells and, in 
turn, the manufacture of monoclonal antibodies is 
of particular interest. It is possible to manufacture 
mouse and human hybridoma cells by electrofu- 
sion [7,21,27], but so far the yields have been low. 
In this communication we report on the produc- 
tion of high yields of mouse hybridoma cells by 
electrofusion and on the cloning of hybrids ob- 
tained in this manner. 
2. MATERIALS AND METHODS 
2.1. Ceils 
HAT-sensitive SP2/0 myeloma cells were cul- 
tured in RPM1 1640 medium supplemented with 
HT as well as 10% fetal calf serum (FCS). The 
myeloma cells were used for fusion when they 
reached the logarithmic growth phase. Lympho- 
cytes were isolated from the spleen of a mouse 
(BALBlc), and any undesirable rythrocytes were 
lysed with the aid of NH&I (0.85%). Lymphocytes 
isolated in this manner were stored in RPM1 1640 
at 4°C until required for fusion. 
2.2. Fusion pretreatment 
Myeloma cells and lymphocytes were mixed in a 
ratio of 1: 10 or 1: 5, finally producing a total 
number of celis of 1.1 x 10’ per ml. Before being 
introduced into the fusion chamber, the cells were 
twice washed in a medium of the following com- 
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position: 280 mM inositol, 1 mM phosphate buffer 
(K2HP04/KH2P0& 0.5 mM magnesium acetate 
and 0.1 mM calcium acetate. 
2.3. Fusion chamber 
140 ~1 of cell suspension prepared in this way 
were transferred into the so-called helical chamber 
[8,28]. The helical chamber consists of two perspex 
cylinders, one inside the other and each sealed at 
one end. Two platinum wires (diameter 0.2 mm) 
are wound round the inner cylinder in such a way 
that the distance between them is 0.2 mm through- 
out. The result is a helical arrangement of the wires 
[8,28]. The fusion device marketed by GCA Corp. 
Chicago, 111, USA, was used for the fusion of the 
cells. 
3. RESULTS AND DISCUSSION 
Once in the helical chamber, the cells were made 
to align themselves in pearl chains by applying an 
alternating electric field. The field strength of the 
applied alternating electric field was 250 V . cm-‘, 
the frequency 1.5 MHz. The alternating electric 
field was applied for 30 s. After 30 s three square 
pulses of 3.5 kV . cm-’ and 20 pcrs duration were ap- 
plied at intervals of 1 s, which induced an electrical 
breakdown of the cell membranes in the membrane 
contact zones. The alternating electric field which 
had been switched off during the application of the 
square pulses was then re-applied for a further 30 s 
so that the cells were maintained in their relative 
positions to one another. The helical chamber was 
subsequently transferred to an incubation chamber 
(or water bath) for 10 min at 37°C. After incuba- 
tion the inner core with the wire helix was carefully 
removed, and warm (37°C) post-fusion medium of 
the following composition was carefully added to 
the cell suspension: 132 mM NaCl, 8 mM KCl, 10 
mM phosphate buffer, 0.5 mM magnesium acetate 
and 0.1 mM calcium acetate, The cells were in- 
cubated in this medium for a further 30 min in an 
incubation chamber at 37°C. After 30 min the cell 
suspension was centrifuged at 2OOxg, and the 
supernatant decanted. The cells were resuspended 
in RPM1 1640/10% FCS/HAT and transferred in 
units of 3 x lo6 cells to a previously prepared 
feeder layer of peritoneal macrophages (24-well 
Costar microtitre plate). The density of the macro- 
phages was about lo4 cells per well. 
The described procedure resulted in the recovery 
of a large number of live mouse hybridoma cells 
from the microtitre wells 4 days after fusion. On 
average up to 100 clones were recovered from each 
well containing RPM1 1640/HAT medium. Divi- 
sion of the hybridoma cells was normally observed 
after 3 to 4 days. 
In contrast to the studies of Teissie and co- 
workers [ 18,191 and Lo et al. [26], cell contact in 
our experiments was always established with the 
aid of dielectrophoresis. This means that the pro- 
cess is not restricted to certain cell types nor does 
it rely on complicated chemical reactions such as 
the adhesion of antigen/antibody structures to cell 
surfaces. The method thus retains its universal ap- 
plicability. 
The main prerequisites for a high yield of viable 
hybridoma cells are the fusion medium, the reseal- 
ing medium and the intervals between the addition 
of the various media. Contrary to our earlier 
published studies of hybridoma cells [21,27], the 
addition of pronase is no longer necessary if cells 
in the logarithmic growth phase are fused in the 
medium described above. Since the formation of a 
new spherical hybrid - after the breakdown pulse 
has been applied - needs some time, it is necessary 
to allow a certain amount of time between the ap- 
plication of the electric field pulse and the addition 
of the resealing medium. A period of about 10 min 
has been found to be appropriate, although in- 
completely rounded-off fusion products can still 
be observed after 30 min. 
Since the membrane is only incompletely reseal- 
ed 10 min after pulse application at 37”C, the addi- 
tion of substances that might be toxic to the 
permeabilized cells must be avoided under all cir- 
cumstances. This includes the addition of nutrient 
media containing dyes such as neutral red or 
phenol red. 
The use of these solutions and field conditions 
leads to a high yield of hybridoma cells in a very 
reproducible manner. A further increase in the 
yield of hybridoma cells can be expected in the 
light of the results obtained for the fusion of yeast 
cells [28,29]. With yeast cells the yield of hybrids 
could be increased from 60 hybrids per run [28] to 
more than 4000 [29], by using an adequate fusion 
medium and appropriate field and incubation con- 
ditions which have a beneficial effect on the 
growth (regenerative capacity) of these cells. We 
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therefore believe that further efforts in this field 
should be directed towards further improvement 
of the composition of the fusion and post-fusion 
media and further optimisation of the field condi- 
tions. Alternative ways of establishing membrane 
contact, as mentioned in the introduction, may be 
very useful for certain applications, but in our opi- 
nion they place too great a restriction on the 
diverse and universal applications of this method. 
The potential of this method for the manufacture 
of hybridoma cells should be further augmented by 
the fact that it is possible, by means of electrical 
fields, to separate out antibody-secreting lym- 
phocytes for alignment with myeloma cells in the 
alternating electric field [6]. The resulting hybrid- 
oma cells secrete monoclonal antibodies per se 
under these conditions. 
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